Cancer Journal Publishes Response to Lymphoma Treatment Study Critique

Researchers have submitted a formal response to criticism of their mantle cell lymphoma treatment findings in the Journal of the National Cancer Institute. The exchange signals ongoing debate within oncology about which drug combinations deliver the best long-term survival for patients with this aggressive blood cancer.

Originaltitel: Response to Drs Zhe Zhang and Hongbo Wu